Investment Objective and Approach

WhiteOak Capital Pharma and Healthcare Fund seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. This is an open ended equity scheme investing in Pharma and Healthcare sector.

The fund follows a focused sector-based investment approach, targeting companies operating in the pharmaceutical and healthcare segments. The fund has allocated its funds majorly in Health, Cash Equivalent, Government, Basic Materials, Financial Services. Its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Max Healthcare Institute Ltd, Cipla Ltd, and Fortis Healthcare Ltd.

The investment strategy is built around identifying quality pharmaceutical and healthcare companies with strong growth potential. The fund maintains 86.69% allocation in equities, 0.00% in bonds, and 13.31% in cash and cash equivalents as of January 2025.

Fund Managers

The fund is managed by Piyush Baranwal, Ramesh Mantri, and Dheeresh Pathak.

Piyush Baranwal - Lead Fund Manager

He is a B.Tech in Electronics and Communication from Manipal Institute of Technology and completed PGDBM in Finance from S.P.Jain Institute of Management and Research along with CFA. Prior to joining WhiteOak Capital Mutual Fund, he has worked with BOI AXA, Morgan Stanley Investment Management (Jan 2011-June 2014) and Principal PNB AMC as a Dealer-Fixed Income (May 2008-Jan 2011). He is a fixed income professional with over thirteen years of experience managing various fixed income funds in the Indian market.

Ramesh Mantri

Mr. Mantri is an MBA, CFA and CA. He has worked with BOI AXA, Morgan Stanley Investment Management and Principal PNB AMC.

Dheeresh Pathak

Prior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.

About the Fund House (AMC)

WhiteOak Capital Asset Management Limited was founded with the vision of creating a performance-driven investment management company. Prashant Khemka founded White Oak AMC in June 2017 with the goal of creating a performance-driven organization with a strong investment culture. Prashant Khemka is the former CIO of Goldman Sachs Asset Management's India Equity and Global Emerging Markets Equity businesses.

The company has established a strong global presence with operations in India, Singapore, Mauritius, the United Kingdom, and Switzerland. White Oak group entities have a combined AUM of Rs 8,794.84 Cr as of March 31, 2024, with a global client base that includes sovereign wealth funds, pension plans, endowments, individuals, and family offices.

The White Oak Capital Group provides investment management and advisory services for Indian equity, underpinned by strong investment values that aim to deliver tangible results for all stakeholders over the long-term. The company operates on a performance-first mentality that is centered on a straightforward stock selection process and sound risk management.

Key Fund Statistics (as of July 2025):

- AUM: ₹331.66 Crores

- Expense Ratio: 0.7%

- Minimum SIP Amount: ₹100

- Minimum Lumpsum Investment: ₹500

- Exit Load: 1% if redeemed within 31 days

- Fund Launch Date: February 6, 2024

Performance Highlights:

- Returns since inception: 27.19% p.a.

- 1-year returns: 26.32%

- Risk Rating: Very High Risk

Should I Invest in WhiteOak Capital Pharma and Healthcare Fund?

This fund is suitable for investors who:

Ideal For:

- Have a high risk tolerance and can handle sectoral volatility

- Believe in the long-term growth potential of India's pharmaceutical and healthcare sector

- Seek targeted exposure to pharma and healthcare companies

- Can invest for a minimum horizon of 7+ years

- Want to capitalize on India's healthcare transformation story

Consider This Fund If:

- You have experience with sector-specific investments

- Your portfolio needs pharmaceutical sector exposure

- You can stomach significant volatility in pursuit of higher returns

- You prioritize predictability of returns and exceptional consistency

Avoid This Fund If:

- You need to redeem your investment in less than seven years

- You prefer diversified equity funds over sector-focused funds

- You cannot tolerate high volatility

- You're a conservative investor seeking stable returns

Important Considerations:

- Value Research recommends that investors should avoid funds with narrowly defined investment mandates such as this one

- If you do invest, you must do so only through the SIP route

- The fund is relatively new, launched in February 2024, so long-term track record is limited

FAQs

What is today's NAV of WhiteOak Capital Pharma and Healthcare Fund?

The latest NAV is ₹14.028 as of July 4, 2025. NAV is declared daily after market hours and reflects the per-unit value of the fund.

What is the AUM of WhiteOak Capital Pharma and Healthcare Fund?

The fund has an AUM of ₹331.66 Crores as of July 2025. This represents the total value of assets managed by the fund.

What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund?

The expense ratio is 0.7% for the direct plan. This is the annual fee charged by the fund house for managing your investments.

What are the returns of WhiteOak Capital Pharma and Healthcare Fund since inception?

The fund has generated returns of 27.19% p.a. since its inception in February 2024. The 1-year return stands at 25.96%.

What is the minimum SIP amount to invest in WhiteOak Capital Pharma and Healthcare Fund?

The minimum SIP amount is ₹100. You can start investing with this small amount through systematic investment plans.

How do I invest in WhiteOak Capital Pharma and Healthcare Fund?

You can invest through Allvest's platform by completing your KYC, selecting the fund, choosing between SIP or lumpsum, and setting up payment mandates. Allvest offers a seamless digital investment experience.

How to start a SIP in WhiteOak Capital Pharma and Healthcare Fund?

Through Allvest, select the fund, choose SIP option, enter your monthly investment amount (minimum ₹100), select SIP date, and set up auto-debit mandate. Your SIP will start from the next cycle.

How do I automate an SIP in WhiteOak Capital Pharma and Healthcare Fund?

Allvest enables SIP automation through bank mandate or UPI AutoPay. Once set up, your SIP amount will be automatically debited monthly without manual intervention.

How can I withdraw/redeem my investment in WhiteOak Capital Pharma and Healthcare Fund?

You can redeem your units through Allvest's platform anytime. Note that 1% exit load applies if redeemed within 31 days. Redemption proceeds are usually credited within 3-4 working days.